Ph.D. Degree Program
The Pharmaceutical Health Outcomes and Policy (PHOP) doctoral degree program at the University of Houston College of Pharmacy offers a learning and research environment that combines the collaborative opportunities of the Texas Medical Center’s world-class healthcare and scientific community with the academic resources and award-winning faculty at Houston’s only Carnegie Institute-designated Tier One public research university.
Pharmaceutical Health Outcomes and Policy consists of pharmaceutical practice and policy research, a multidisciplinary field that examines cost, access, and quality of pharmaceutical care from clinical, sociobehavioral, economic, organizational and technological perspectives. Traditional and innovative areas of pharmaceutical health outcomes research include pharmacoepidemiology, pharmacoeconomics, comparative effectiveness research, patient-centered outcomes research, and translational research.
The Ph.D. in Pharmaceutical Health Outcomes and Policy requires the completion of a minimum number of 70 credit hours.
For additional details about the program, visit the PHOP PhD page here.
For program admissions information, visit the PhD Graduate Admissions page here.
To download the UHCOP PharmAd Focus Spring 2013 newsletter, please click here.
(Program flier requires Adobe Reader; click here for free download.)